AIDX (AIDX)

NASDAQ: AIDX · USD

$0.24

+0.01 (+2.2%)· Recorded snapshot

Market cap	3.1M
Revenue (ttm)	2M
Net income (ttm)	-7.1M
EPS (ttm)	-$1.00
Shares out	12.8M
Volume	667,995
Beta	-0.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2M
Net income (ttm): -7.1M
EPS (ttm): -$1.00
Market cap: 3.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 20:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-331.2

P25 n/aP50 n/aP75 n/a

ROIC-112.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIDX indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001139685
Country	United States
Country code	US
CUSIP number	90138K101
Earnings date	2026-11-15
Earnings time	amc
Employees	14
Employees change	-6
Employees growth	-30%
Enterprise value	$-908,819
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-09
Fiscal year end	December
Founded	2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US90138K1016
Last 10-K release date	2026-03-31
Last earnings date	2026-08-14
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$3.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-15
Price	$0.24
Price currency	USD
Sector	Healthcare
SIC code	8734
Stock price date	2026-11-04
Symbol	AIDX
U.S. state	Maryland
Website	https://2020biolabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-416.53%
FCF / EV yield	286.64%
FCF yield	-93.07%
Forward P/S	1.53x
Industry forward P/E	20.34x
Industry P/E	39.98x
P/B ratio	1.78x
P/S ratio	1.47x
Price / tangible book value	2.61x
Sector forward P/E	24x
Sector P/E	49.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-215.69%
EBITDA margin	-211.83%
Gross margin	31.52%
Operating margin	-215.69%
Pretax margin	-285%
Profit margin	-285%
Profit per employee	$-508,216
Revenue per employee	$145,729
ROA	-62.37%
ROCE	-123.2%
ROE	-331.22%
ROIC	-112.07%
SBC / revenue	45.98%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	24.58%
Gross profit growth (Q)	86.65%
Gross profit growth 3Y	28.29%
Gross profit growth 5Y	73.02%
Net income growth years	2
Revenue growth	2.73%
Revenue growth (Q)	36.54%
Revenue growth (QoQ)	106.74%
Revenue growth 3Y	-9.17%
Revenue growth 5Y	48.31%
Revenue growth quarters	1
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$78,938
EBIT	$-4.4M
EBITDA	$-4.3M
EPS	$-1.00
FCF per share	$-0.22
Financing cash flow	$6.3M
Free cash flow	$-2.8M
Free cash flow minus SBC	$-3.7M
Gross profit	$643,094
Investing cash flow	$-12,854
Net borrowing	$1.2M
Net cash flow	$3.5M
Net income	$-7.1M
Operating cash flow minus SBC	$-3.7M
Operating income	$-4.4M
Revenue	$2M
Stock-based compensation	$938,120

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.34
Book value per share	$0.13
Debt / equity	0.18
Interest coverage	-6.34
Long-term assets	$1M
Long-term liabilities	$412,641
Net cash (debt)	$4M
Net cash / market cap	132.47%
Net cash growth	1,895.25%
Net debt / equity	-1.26
Piotroski F-Score	3
Property, plant and equipment	$553,002
Shareholders' equity	$3.2M
Tangible book value	$1.1M
Tangible book value per share	$0.09
Total assets	$6.1M
Total cash	$4.5M
Total debt	$572,448
Total liabilities	$3M
WACC	16.95%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.46
Current assets	$5.1M
Current liabilities	$2.6M
Current ratio	1.99
Inventory turnover	16.18
Net working capital	$-1.8M
Quick ratio	1.9
Working capital	$2.5M
Working capital turnover	1.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-47.91%
Dividend yield	0%
Shareholder yield	-47.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.78
1D price change	2.17%
1M price change	-34.34%
1M total return	-34.34%
1W price change	0.6%
1W total return	0.6%
20-day SMA	$0.27
3M price change	-41.4%
3M total return	-41.4%
50-day SMA	$0.41
52-week high	$50.00
52-week high date	2026-02-19
52-week low	$0.21
52-week low date	2026-10-30
6M price change	-83.85%
6M total return	-83.85%
After-hours change	6.43%
After-hours close	$0.23
After-hours price	$0.25
All-time high	$50.00
All-time high date	2026-02-19
All-time low	$0.21
All-time low date	2026-10-30
Average true range (ATR)	$0.03
Average volume	197.4K
Beta (1Y)	2.74
Beta (5Y)	-0.43
Change from 52-week high	-99.52%
Change from 52-week low	14.29%
Change from all-time high	-99.5%
Change from all-time low	18.81%
Change from open	2.13%
Day's gap	0.04%
Dollar volume	$160,319
High price	$0.27
Low price	$0.23
Monthly RSI	0
Open price	$0.24
Position in 52-week range	25.32%
Premarket change	6.22%
Premarket close	$0.23
Premarket price	$0.25
Premarket volume	21.2K
Previous close	$0.23
Price vs 150-day SMA	-67.81%
Price vs 20-day SMA	-8.84%
Price vs 50-day SMA	-38.61%
Relative volume	3.38
RSI	36.2
Sharpe ratio	-4.3
Sortino ratio	-4.6
Volume	668K
Weekly RSI	4.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10.8M
Float percentage	84.92%
Shares change (QoQ)	40.92%
Shares change (YoY)	47.91%
Shares held by insiders	13.24%
Shares held by institutions	6.49%
Shares outstanding	12.8M
Short % of float	0.1%
Short % of shares	0.09%
Short ratio	0.1 days

Deeper analysis on AIDX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIDX report

Is a complete AIDX research report available?

No complete published report is available for AIDX (AIDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIDX (AIDX)

Price

Financial snapshot

Fair-value bridge

Latest news · AIDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIDX

Frequently asked questions